This collection
is approved consistent with FDA's memoranda of 10/26/99 and
11/22/99. In addition, FDA shall ensure that the compilation and
reporting of the survey findings shall note limitations in the
design and generalizability, as discussed with OMB.
Inventory as of this Action
Requested
Previously Approved
04/30/2000
04/30/2000
1
0
0
452
0
0
0
0
0
The proposed collection of information
concerns the current good manufacturing practices of dietary
supplement establishments. The objectives are to (1) learn about
existing practices and (2) help FDA formulate a policy to ensure
that dietary supplements are produced under conditions that will
result in a safe and properly labeled product without unnecessary
costs to the industry. The survey will provide an understanding of
the economic impact that any proposed regulations will have on the
industry.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.